Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Postpones Q4, FY 2011 Earnings Release to Mull Over Roche's Hostile Bid

NEW YORK (GenomeWeb News) – Illumina today postponed the release of its fourth-quarter and full-year 2011 financial results as its board reviews Roche's $5.7 million hostile bid for the San Diego-based next-generation sequencing and microarray firm.

Illumina also reaffirmed preliminary results announced earlier this month at the JP Morgan Healthcare Conference.

The company said that it will reschedule its earnings results release, which had been set for Jan. 31, "concurrent with the board's completion of its review of Roche's unsolicited tender offer and the issue of its recommendation."

Roche launched its hostile bid late Tuesday with an offer to buy all outstanding shares of Illumina for $44.50 per share. Yesterday, Illumina adopted a poison pill plan in an effort to thwart Roche's maneuver, and last night Roche responded by saying it was "disappointed" with Illumina's actions.

Illumina said today that its board will advise shareholders of its formal position on Roche's tender offer within 10 business days and reiterated that shareholders should take no action until the board has finished its review.

In the meantime, the company reaffirmed preliminary fourth-quarter estimates of about $250 million in revenues and pro forma earnings per share of $.34. It also reiterated that it expects to meet or exceed analysts' expectations for 2012. It will resume providing guidance on the fourth-quarter earnings call.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.